Back Article

  • Beck J, Nassal M. Hepatitis B virus replication[J]. World J Gastroenterol, 2007, 13(): 48-64. doi: 10.3748/wjg.v13.i1.48

  • Bellecave P, Andreola M L, Ventura M. Selection of DNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus and inhibit viral RNA synthesis in vitro[J]. Oligonucleotides, 2003, 13(): 455-463. doi: 10.1089/154545703322860771

  • Bellecave P, Cazenave C, Rumi J. Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells[J]. Antimicrob Agents Chemother, 2008, 52(6): 2097-2110. doi: 10.1128/AAC.01227-07

  • Biroccio A, Hamm J, Incitti I. Selection of RNA aptamers that are specific and high affinity ligands of the hepatitis C virus-dependent RNA polymerase[J]. J Virol, 2002, 76(): 3688-3696. doi: 10.1128/JVI.76.8.3688-3696.2002

  • Bryant K F, Cox J C, Wang H. Binding of herpes simplex virus-1US11 to specific RNA sequences[J]. Nucleic Acids Res, 2005, 33(): 6090-6100. doi: 10.1093/nar/gki919

  • Colas P, Cohen B, Jessen T. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2[J]. Nature, 1996, 380(6574): 548-550. doi: 10.1038/380548a0

  • Ellington A D, Szostak J W. In vitro selection of RNA molecules that bind specific ligands[J]. Nature, 1990, 346(): 818-828. doi: 10.1038/346818a0

  • Fukuda K, Vishnuvardhan D, Sekiya S. Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease[J]. Eur J Biochem, 2000, 267(): 3685-3694. doi: 10.1046/j.1432-1327.2000.01400.x

  • Gopinath S C B, Misono T, Mizuno T. An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits hemagglutinin-mediated membrane fusion[J]. J Gen Virol, 2006, 87(): 479-487. doi: 10.1099/vir.0.81508-0

  • Gopinath S C B, Sakamaki Y, Kawasaki K. An efficient RNA aptamer against human influenza B virus hemagglutinin[J]. J Biochem, 2006, 139(): 837-846. doi: 10.1093/jb/mvj095

  • Gopinath S C B. Antiviral aptamers[J]. Arch Virol, 2007, 152(): 2137-2157. doi: 10.1007/s00705-007-1014-1

  • Hu K, Beck J, Nassal M. SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of rever transcription[J]. Nucleic Acids Res, 2004, 32(): 4377-4389. doi: 10.1093/nar/gkh772

  • James W. Aptamers in the virologists' toolkit[J]. J Gen Virol, 2007, 88(): 351-364. doi: 10.1099/vir.0.82442-0

  • Jones L A, Clancy L E, Rawlinson W D. High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity[J]. Antimicrob Agents Chemother, 2006, 50(9): 3019-3027. doi: 10.1128/AAC.01603-05

  • Kikuchi K, Umehara T, Fukuda K. A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain Ⅲ-Ⅳ-targeted aptamer inhibits translation by binding to an apical loop of domain Ⅲd[J]. Nucl Acids Res, 2005, 33(): 683-692. doi: 10.1093/nar/gki215

  • Konno K, Nishikawa S, Hasegawa T. Isolation of RNA aptamers specific for the HCV minus-IRES domain Ⅰ[J]. Nucl Acids Symp Series, 2007, 51(): 393-394. doi: 10.1093/nass/nrm197

  • Kumar P K R, Machida K, Urvil P T. Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA[J]. Virology, 1997, 237(): 270-282. doi: 10.1006/viro.1997.8773

  • Lee S, Kim Y S, Jo M. Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen[J]. Biochem Biophys Res Commun, 2007, 358(1): 47-52. doi: 10.1016/j.bbrc.2007.04.057

  • Lohmann V, Korner F, Koch J. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line[J]. Science, 1999, 285(): 110-113. doi: 10.1126/science.285.5424.110

  • Nassal M. Hepatitis B virus: reverse transcription a different way[J]. Virus Res, 2008, 134(): 235-249. doi: 10.1016/j.virusres.2007.12.024

  • Ng E W M, Shima D T, Calias P. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease[J]. Nat Rev Drug Discov, 2006, 5(): 123-132. doi: 10.1038/nrd1955

  • Nulf C J, Corey D. Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs)[J]. Nucl Acids Res, 2004, 32(): 3792-3798. doi: 10.1093/nar/gkh706

  • Pileur F, Andreola M, Dausse E. Selective inhibitory DNA aptamers of the human RNase H1[J]. Nucl Acids Res, 2003, 31(): 5776-5788. doi: 10.1093/nar/gkg748

  • Rosenberg S. Recent advances in the molecular biology of hepatitis C virus[J]. J Mol Biol, 2001, 313(): 451-464. doi: 10.1006/jmbi.2001.5055

  • Schultz U, Grgacic E, Nassal M. Duck hepatitis B virus: an invaluable model system for HBV infection[J]. Adv Virus Res, 2004, 63(): 1-70. doi: 10.1016/S0065-3527(04)63001-6

  • Tallet-Lopez B, Aldaz-Carroll L, Chabas S. Antisense oligonucleotides targeted to the domain Ⅲd of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation[J]. Nucleic Acids Res, 2003, 31(): 734-742. doi: 10.1093/nar/gkg139

  • Tomai E, Butz K, Lohrey C. Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes[J]. J Biol Chem, 2006, 281(30): 21345-21352. doi: 10.1074/jbc.M604258200

  • Trahtenherts A, Gal-Tanamy M, Zemel R. Inhibition of hepatitis C virus RNA replicons by peptide aptamers[J]. Antiviral Res, 2008, 77(3): 195-205. doi: 10.1016/j.antiviral.2007.12.013

  • Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase[J]. Science, 1990, 249(): 505-510. doi: 10.1126/science.2200121

  • Umehara T, Fukuda K, Nishikawa F. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3[J]. J Biochem (Tokyo), 2005, 137(): 339-347. doi: 10.1093/jb/mvi042

  • Urvil P T, Kakiuchi N, Zhou D M. Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus[J]. Eur J Biochem, 1997, 248(): 130-138. doi: 10.1111/ejb.1997.248.issue-1